<DOC>
	<DOCNO>NCT02509650</DOCNO>
	<brief_summary>The primary purpose protocol use next generation sequence identify pathogenic variant gene involve rare skin disease . The secondary purpose study genotype-phenotype correlation order re-evaluate classification disorder . This work could help understand physiopathology rare skin disorder .</brief_summary>
	<brief_title>Identification Mutations Responsible Rare Familial Skin Diseases Next Generation Sequencing</brief_title>
	<detailed_description />
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Lipomatosis</mesh_term>
	<criteria>patient affect familial lipomatosis patient rare dermatologic disease without molecular diagnosis write informed consent obtain patient his/her family patient want participate protocol patient already include another study use next generation sequence technology</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Exome sequencing</keyword>
	<keyword>Skin disease</keyword>
	<keyword>Familial lipomatosis</keyword>
</DOC>